United KingdomSophie Ashton, a 39-year-old woman from Greater Manchester, started taking Wegovy pills as a cheaper alternative to the injectable weight loss drug Mounjaro, which she could no longer afford due to rising costs. After losing one-and-a-half stone while on Mounjaro, she hoped the pill would offer similar results. However, within ten days of starting Wegovy, she experienced severe side effects including constant anxiety, insomnia, irritability, and depression. Her mental state deteriorated significantly, to the point where her three-year-old daughter noticed her distress. When she reported these issues to the prescribing service, she was advised to switch back to injections, despite her reluctance due to previous negative experiences with weight loss drugs. Experts warn that the higher oral dose of semaglutide in Wegovy pills may contribute to a range of adverse effects, raising concerns about the safety and effectiveness of the medication compared to its injectable counterpart.
Bias read (Progressive): The article frames the controversy around Wegovy's side effects as a broader issue of affordability and access to healthcare, particularly highlighting the financial burden on patients who can no longer afford injectable treatments. While the medical aspects are discussed objectively, the emphasis -
